220 related articles for article (PubMed ID: 30685537)
1. Pathogenic effects of anti-citrullinated protein antibodies in rheumatoid arthritis - role for glycosylation.
Coutant F
Joint Bone Spine; 2019 Oct; 86(5):562-567. PubMed ID: 30685537
[TBL] [Abstract][Full Text] [Related]
2. Anti-Citrullinated Protein Antibodies in Patients with Rheumatoid Arthritis: Biological Effects and Mechanisms of Immunopathogenesis.
Wu CY; Yang HY; Lai JH
Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32512739
[TBL] [Abstract][Full Text] [Related]
3. Different Hierarchies of Anti-Modified Protein Autoantibody Reactivities in Rheumatoid Arthritis.
Sahlström P; Hansson M; Steen J; Amara K; Titcombe PJ; Forsström B; Stålesen R; Israelsson L; Piccoli L; Lundberg K; Klareskog L; Mueller DL; Catrina AI; Skriner K; Malmström V; Grönwall C
Arthritis Rheumatol; 2020 Oct; 72(10):1643-1657. PubMed ID: 32501655
[TBL] [Abstract][Full Text] [Related]
4. N-Linked Glycans in the Variable Domain of IgG Anti-Citrullinated Protein Antibodies Predict the Development of Rheumatoid Arthritis.
Hafkenscheid L; de Moel E; Smolik I; Tanner S; Meng X; Jansen BC; Bondt A; Wuhrer M; Huizinga TWJ; Toes REM; El-Gabalawy H; Scherer HU
Arthritis Rheumatol; 2019 Oct; 71(10):1626-1633. PubMed ID: 31067000
[TBL] [Abstract][Full Text] [Related]
5. The structure, specificity and function of anti-citrullinated protein antibodies.
Ge C; Holmdahl R
Nat Rev Rheumatol; 2019 Aug; 15(8):503-508. PubMed ID: 31253945
[TBL] [Abstract][Full Text] [Related]
6. From Rheumatoid Factor to Anti-Citrullinated Protein Antibodies and Anti-Carbamylated Protein Antibodies for Diagnosis and Prognosis Prediction in Patients with Rheumatoid Arthritis.
Wu CY; Yang HY; Luo SF; Lai JH
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33445768
[TBL] [Abstract][Full Text] [Related]
7. Triple Positivity for Anti-Citrullinated Protein Autoantibodies, Rheumatoid Factor, and Anti-Carbamylated Protein Antibodies Conferring High Specificity for Rheumatoid Arthritis: Implications for Very Early Identification of At-Risk Individuals.
Verheul MK; Böhringer S; van Delft MAM; Jones JD; Rigby WFC; Gan RW; Holers VM; Edison JD; Deane KD; Janssen KMJ; Westra J; Brink M; Rantapää-Dahlqvist S; Huizinga TWJ; van der Helm-van Mil AHM; van der Woude D; Toes REM; Trouw LA
Arthritis Rheumatol; 2018 Nov; 70(11):1721-1731. PubMed ID: 29781231
[TBL] [Abstract][Full Text] [Related]
8. Peptidylarginine Deiminase Autoimmunity and the Development of Anti-Citrullinated Protein Antibody in Rheumatoid Arthritis: The Hapten-Carrier Model.
Auger I; Balandraud N; Massy E; Hemon MF; Peen E; Arnoux F; Mariot C; Martin M; Lafforgue P; Busnel JM; Roudier J
Arthritis Rheumatol; 2020 Jun; 72(6):903-911. PubMed ID: 31820586
[TBL] [Abstract][Full Text] [Related]
9. HLA and anti-citrullinated protein antibodies: Building blocks in RA.
van der Woude D; Catrina AI
Best Pract Res Clin Rheumatol; 2015 Dec; 29(6):692-705. PubMed ID: 27107507
[TBL] [Abstract][Full Text] [Related]
10. Autoantibody and metalloproteinase activity in early arthritis.
Ponikowska M; Świerkot J; Nowak B; Korman L; Wiland P
Clin Rheumatol; 2019 Mar; 38(3):827-834. PubMed ID: 30406565
[TBL] [Abstract][Full Text] [Related]
11. The current status of anti-citrullinated protein antibodies and citrullinated protein-reactive B cells in the pathogenesis of rheumatoid arthritis.
He J; Ju J; Wang X
Mol Biol Rep; 2022 Mar; 49(3):2475-2485. PubMed ID: 34855107
[TBL] [Abstract][Full Text] [Related]
12. Evolution of autoantibody responses in individuals at risk of rheumatoid arthritis.
Falkenburg WJJ; van Schaardenburg D
Best Pract Res Clin Rheumatol; 2017 Feb; 31(1):42-52. PubMed ID: 29221597
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance of anti-CCP antibodies in rheumatoid arthritis.
Mimori T
Intern Med; 2005 Nov; 44(11):1122-6. PubMed ID: 16357447
[TBL] [Abstract][Full Text] [Related]
14. Pathogenic Citrulline-Multispecific B Cell Receptor Clades in Rheumatoid Arthritis.
Titcombe PJ; Wigerblad G; Sippl N; Zhang N; Shmagel AK; Sahlström P; Zhang Y; Barsness LO; Ghodke-Puranik Y; Baharpoor A; Hansson M; Israelsson L; Skriner K; Niewold TB; Klareskog L; Svensson CI; Amara K; Malmström V; Mueller DL
Arthritis Rheumatol; 2018 Dec; 70(12):1933-1945. PubMed ID: 29927106
[TBL] [Abstract][Full Text] [Related]
15. Anti-cyclic citrullinated peptide antibodies, other common autoantibodies, and smoking as risk factors for lymphoma in patients with rheumatoid arthritis.
Baecklund E; Backlin C; Rönnelid J; Toes R; Huizinga T; Åhlin E; Askling J; Hochberg FH; Klareskog L; Kay J; Smedby KE
Scand J Rheumatol; 2018 Jul; 47(4):270-275. PubMed ID: 29336646
[TBL] [Abstract][Full Text] [Related]
16. The pathogenic potential of autoreactive antibodies in rheumatoid arthritis.
Bax M; Huizinga TW; Toes RE
Semin Immunopathol; 2014 May; 36(3):313-25. PubMed ID: 24763532
[TBL] [Abstract][Full Text] [Related]
17. The autoantibody response to cyclic citrullinated collagen type II peptides in rheumatoid arthritis.
Liang B; Ge C; Lönnblom E; Lin X; Feng H; Xiao L; Bai J; Ayoglu B; Nilsson P; Nandakumar KS; Zhao M; Holmdahl R
Rheumatology (Oxford); 2019 Sep; 58(9):1623-1633. PubMed ID: 30892636
[TBL] [Abstract][Full Text] [Related]
18. [The pathogenic role of ACPA in rheumatoid arthritis].
Umeda N; Matsumoto I; Sumida T
Nihon Rinsho Meneki Gakkai Kaishi; 2017; 40(6):391-395. PubMed ID: 29367523
[TBL] [Abstract][Full Text] [Related]
19. Structural Basis of Cross-Reactivity of Anti-Citrullinated Protein Antibodies.
Ge C; Xu B; Liang B; Lönnblom E; Lundström SL; Zubarev RA; Ayoglu B; Nilsson P; Skogh T; Kastbom A; Malmström V; Klareskog L; Toes REM; Rispens T; Dobritzsch D; Holmdahl R
Arthritis Rheumatol; 2019 Feb; 71(2):210-221. PubMed ID: 30152126
[TBL] [Abstract][Full Text] [Related]
20. ACPA IgG galactosylation associates with disease activity in pregnant patients with rheumatoid arthritis.
Bondt A; Hafkenscheid L; Falck D; Kuijper TM; Rombouts Y; Hazes JMW; Wuhrer M; Dolhain RJEM
Ann Rheum Dis; 2018 Aug; 77(8):1130-1136. PubMed ID: 29615411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
